RxDoctor Payments Data

Christen Cawley, PA

Medical · Pittsburgh, PANPI 1538560511

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 480 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,887 and has fallen 63.0% since, to $1,436 in 2023. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,347in general payments, 2019–2025

Across 480 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$780
  • Pfizer$490
  • Daiichi Sankyo Inc.$407
  • AstraZeneca$381
  • Incyte Corporation$309
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,18598%
  • Education$1622%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,347 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$3,996
Medicare patients
58
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl108$979
SsdSilver Sulfadiazine16$241
Fluconazole15$151
Hydrocortisone12$83
Oxycodone Hcl12$76

Paid to pharmacies, not to this prescriber.

Other medical in Pittsburgh

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →